mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.009 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.16 |
0.01 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |